Role of exposure analysis in solving the mystery of balkan endemic nephropathy

Croatian Medical Journal

Volumn 48, Issue 3, 2007, Pages 300-311

  Long, David T ^a   Voice, Thomas C ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID; OCHRATOXIN;

EXPOSURE; GOITER; HEALTH SCIENCE; HUMAN; INGESTION; INTERSTITIAL NEPHRITIS; NONHUMAN; REVIEW;

ARISTOLOCHIA; ARISTOLOCHIC ACIDS; BALKAN NEPHROPATHY; CROATIA; ENVIRONMENTAL EXPOSURE; GOITER, ENDEMIC; HUMANS; OCHRATOXINS;

EID: 34447129616     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Voice TC, Long DT, Radovanovic Z, Atkins JL, McElmurry SP, Niagolova ND, et al. Critical evaluation of environmental exposure agents suspected in the etiology of Balkan endemic nephropathy. Int J Occup Environ Health. 2006;12:369-76.
2. Stefanovic V, Toncheva D, Atanasova S, Polenakovic M. Etiology of Balkan endemic nephropathy and associated urothelial cancer. Am J Nephrol. 2006;26:1-11.
3. Maver H, Rudan P, editors. Recent advances in endemic nephropathy. Zagreb: Collegium Antropol. 2006; 30 Suppl l.
4. Ott W. Total human exposure: an emerging science focuses on humans as receptors of environmental pollution. Environ Sci Technol. 1985;19:880-6.
5. Ott WR, Steinemann AC, Wallace LA, editors. Exposure analysis. Ann Arbor: CRC Press; 2006.
6. Lioy PJ. Measurement methods for human exposure analysis. Environ Health Perspect. 1995;103 Suppl 3:35-43.
7. Rangan U, Hedli C, Gallo M, Lioy P, Snyder R. Exposure and risk assessment with respect to contaminated soil: significant biomarkers and bioavailability. Int J Toxicol. 1997;16:419-32.
8. Weis BK, Balshaw D, Barr JR, Brown D, Ellisman M, Lioy P, et al. Personalized exposure assessment: promising approaches for human environmental health research. Environ Health Perspect. 2005;113:840-8.
9. Sos J. Geographical distribution and the relevant pathogenetical relationship of endemic goiter. Geogr Med. 1969-70;1:11-4.
10. Greenwald I. The significance of the history of goiter for the etiology of the disease. Am J Clin Nutr. 1960;8:801-7.
11. Schiel JB Jr, Wepfer AJ. Distributional aspects of endemic goiter in the United States. Econ Geogr. 1976;52:116-22.
12. McClendon J, Williams A. Simple goiter as a result of iodine deficiency. JAMA. 1923;80:600-1.
13. Courtois B. Discovery of a new substance in the kelp [In French]. Ann Chim. 1813;88:304-10.
14. Coindet J. Discovery of a new remedy against goiter [In French]. Ann Clin Phys. 1820:49.
15. McClendon J. The distribution of iodine with special reference to goiter. Physiol Rev. 1927;7:25-30.
16. Lin NF, Tang J, Bian JM. Geochemical environment and health problems in China. Environ Geochem Health. 2004;26:81-8.
17. Fordyce FM, Johnson CC, Navaratna UR, Appleton JD, Dissanayake CB. Selenium and iodine in soil, rice and drinking water in relation to endemic goitre in Sri Lanka. Sci Total Environ. 2000;263:127-41.
18. Fuge R, Johnson C. The geochemistry of iodine: a review. Environ Geochem Health. 1985;8:31-54.
19. Booth N, Krabbenhoft D, Saltman T. Mapping modeled national-scale vulnerability to mercury loading across the United States: a new use for nationally available and consistent aquatic and terrestrial databases. In: Eighth International Conference on Mercury as a Global Pollutant. Aug 6-11, 2006. Madison (WI): University of Wisconsin; 2006.
20. de Benoist B, Andersson M, Egli I, Takkouche B, Allen H, editors. Iodine status worldwide. Geneva: World Health Organization; 2004.
21. Ezaki H, Ebihara S, Fujimoto Y, Iida F, Ito K, Kuma K, et al. Analysis of thyroid carcinoma based on material registered in Japan during 1977-1986 with special reference to predominance of papillary type. Cancer. 1992;70:808-14.
22. Kusic Z, Jukic T. History of endemic goiter in Croatia: from severe iodine deficiency to iodine sufficiency. Coll Antropol. 2005;29:9-16.
23. McNeil DG Jr. In raising the world's I.Q., the secret's in the salt. New York Times. Dec 16, 2006. Available from: http://www.nytimes.com/2006/12/16/ health/16iodine.html?ex=1323925200&en=8774496ea20281f7&ei=5090. Accessed: February 26, 2007.
24. van der Merwe KJ, Steyn PS, Fourie L, Scott DB, Theron JJ. Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature. 1965;205:1112-3.
25. Moss MO. Mycotoxin review - 1. Aspergillus and Penicillium. Mycologist. 2002;16:116-9.
26. Fung F, Clark RF. Health effects of mycotoxins: a toxicological overview. J Toxicol Clin Toxicol. 2004;42:217-34.
27. Clark HA, Snedeker SM. Ochratoxin a: its cancer risk and potential for exposure. J Toxicol Environ Health B Crit Rev. 2006;9:265-96.
28. Hassen W, Abid-Essafi S, Achour A, Guezzah N, Zakhama A, Ellouz F, et al. Karyomegaly of tubular kidney cells in human chronic interstitial nephropathy in Tunisia: respective role of Ochratoxin A and possible genetic predisposition. Hum Exp Toxicol. 2004;23:339-46.
29. Lebrun S, Golka K, Schulze H, Follmann W. Glutathione S-transferase polymorphisms and ochratoxin A toxicity in primary human urothelial cells. Toxicology. 2006;224:81-90.
30. Al-Anati L, Petzinger E. Immunotoxic activity of ochratoxin A. J Vet Pharmacol Ther. 2006;29:79-90.
31. Ozcelik N, Kosar A, Soysal D. Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol Lett. 2001;121:9-13.
32. Walker R, Larsen JC. Ochratoxin A: previous risk assessments and issues arising. Food Addit Contam. 2005;22 Suppl 1:6-9.
33. Hussein HS, Brasel JM. Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology. 2001;167:101-34.
34. Pardo E, Marin S, Sanchis V, Ramos AJ. Prediction of fungal growth and ochratoxin A production by Aspergillus ochraceus on irradiated barley grain as influenced by temperature and water activity. Int J Food Microbiol. 2004;95:79-88.
35. Pardo E, Sanchis V, Ramos AJ. Impact of relative humidity and temperature on visible fungal growth and OTA production of ochratoxigenic Asperigillus ochraceus isolated on grapes. Food Microbiol. 2005;22:383-9.
36. Lindblad M, Johnsson P, Jonsson N, Lindqvist R, Olsen M. Predicting noncompliant levels of ochratoxin A in cereal grain from Penicillium verrucosum counts. J Appl Microbiol. 2004;97:609-16.
37. Elmholt S. Ecology of the ochratoxin A producing Penicillium verrucosum: occurence in field soil and grain with special attention to farming system and on-farm drying practices. Biol Agric Hortic. 2003;20:311-37.
38. Blesa J, Soriano JM, Molto JC, Manes J. Factors affecting the presence of ochratoxin A in wines. Crit Rev Food Sci Nutr. 2006;46:473-8.
39. Kuiper-Goodman T, Scott PM. Risk assessment of the mycotoxin ochratoxin A. Biomed Environ Sci. 1989;2:179-248.
40. Battilani P, Pietri A, Bertuzzi T, Languasco L, Giorni P, Kozakiewicz Z. Occurrence of ochratoxin A-producing fungi in grapes grown in Italy. J Food Prot. 2003;66:633-6.
41. Otteneder H, Majerus P. Occurrence of ochratoxin A (OTA) in wines: influence of the type of wine and its geographical origin. Food Addit Contam. 2000;17:793-8.
42. Stefanaki I, Foufa E, Tsatsou-Dritsa A, Dais P. Ochratoxin A concentrations in Greek domestic wines and dried vine fruits. Food Addit Contam. 2003;20:74-83.
43. Krogh P, Hald B, Plestina R, Ceovic S. Balkan (endemic) nephropathy and foodborn ochratoxin A: preliminary results of a survey of foodstuffs. Acta Pathol Microbiol Scand [B]. 1977;85:238-40.
44. Petkova-Bocharova T, Castegnaro M. Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria. Food Addit Contam. 1985;2:267-70.
45. Radic B, Fuchs R, Peraica M, Lucic A. Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol Lett. 1997;91:105-9.
46. Vrabcheva T, Usleber E, Dietrich R, Martlbauer E. Cooccurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J Agric Food Chem. 2000;48:2483-8.
47. Puntaric D, Bosnir J, Smit Z, Skes I, Baklaic Z. Ochratoxin A in corn and wheat: geographical association with endemic nephropathy. Croat Med J. 2001;42:175-80.
48. Abouzied MM, Horvath AD, Podlesny PM, Regina NP, Metodiev VD, Kamenova-Tozeva RM, et al. Ochratoxin A concentrations in food and feed from a region with Balkan Endemic Nephropathy. Food Addit Contam. 2002;19:755-64.
49. Vrabcheva T, Petkova-Bocharova T, Grosso F, Nikolov I, Chernozemsky IN, Castegnaro M, et al. Analysis of ochratoxin A in foods consumed by inhabitants from an area with balkan endemic nephropathy: a 1 month follow-up study. J Agric Food Chem. 2004;52:2404-10.
50. Pfohl-Leszkowicz A, Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Addit Contam. 2002;19:282-302.
51. Domijan AM, Peraica M, Zlender V, Cvjetkovic B, Jurjevic Z, Topolovec-Pintaric S, et al. Seed-borne fungi and ochratoxin A contamination of dry beans (Phaseolus vulgaris L.) in the Republic of Croatia. Food Chem Toxicol. 2005;43:427-32.
52. Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food Addit Contam. 1988;5:299-301.
53. Castegnaro M, Canadas D, Vrabcheva T, Petkova-Bocharova T, Chernozemsky IN, Pfohl-Leszkowicz A. Balkan endemic nephropathy: role of ochratoxins A through biomarkers. Mol Nutr Food Res. 2006;50:519-29.
54. Pfohl-Leszkowicz A, Castegnaro M. Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation. Food Addit Contam. 2005;22 Suppl 1:75-87.
55. Manderville RA. A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction. Chem Res Toxicol. 2005;18:1091-7.
56. Mally A, Dekant W. DNA adduct formation by ochratoxin A: review of the available evidence. Food Addit Contam. 2005;22 Suppl 1:65-74.
57. Turesky RJ. Perspective: ochratoxin A is not a genotoxic carcinogen. Chem Res Toxicol. 2005;18:1082-90.
58. Arlt VM, Pfohl-Leszkowicz A, Cosyns J, Schmeiser HH. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat Res. 2001;494:143-50.
59. Abid S, Hassen W, Achour A, Skhiri H, Maaroufi K, Ellouz F, et al. Ochratoxin A and human chronic nephropathy in Tunisia: is the situation endemic? Hum Exp Toxicol. 2003;22:77-84.
60. Halstensen AS, Nordby KC, Elen O, Eduard W. Ochratoxin A in grain dust - estimated exposure and relations to agricultural practices in grain production. Ann Agric Environ Med. 2004;11:245-54.
61. Kovalsky VV. Geochemical ecology and problems of health. Philos Trans R Soc Lond B Biol Sci. 1979;288:185-91.
62. EFSA Opinion of the CONTAM Panel related to ochratoxin A in food. Available from: http://www.efsa.europa.eu/en/science/contam/contam_opinions/ 1521.html. Accessed: December 17, 2006.
63. Knasmuller S, Cavin C, Chakraborty A, Darroudi F, Majer BJ, Huber WW, et al. Structurally related mycotoxins ochratoxin A, ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: implications for risk assessment. Nutr Cancer. 2004;50:190-7.
64. Arlt VM, Ferluga D, Stiborova M, Pfohl-Leszkowicz A, Vukelic M, Ceovic S, et al. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer. 2002;101:500-2.
65. Shibutani S, Suzuki N, Fernandes A, Leko N, Jelakovic B, Grollman AP. Balkan endemic nephropathy: A preventable environmental disease. Cancer Epidemiol Biomarkers Prev. 2005;14:2717S-2717S.
66. Kazantzis G. Comment in the general discussion: possible nephrotoxic agents. In: Wolstenholme GE, Knight J, editors. The Balkan nephropathy. Boston (MA): Ciba Foundation; 1967. p. 114.
67. Ivic M. Etiology of endemic nephropathy [in Croatian]. Lijec Vjesn. 1969;91:1273-81.
68. Hranjec T. KovacPejic A, Kos J, Dika Z, Brzic I, Mao WY, et al. Dietary exposure to Aristolochia clematitis is a risk factor for endemic nephropathy. In: Maver H, Rudan P, editors. Recent advances in endemic nephropathy 2006; Zagreb: Collegium Antropol. 2006; 30 Suppl 1:37.
69. Hranjec T, Kovac A, Kos J, Mao W, Chen JJ, Grollman AP, et al. Endemic nephropathy: the case for chronic poisoning by aristolochia. Croat Med J. 2005;46:116-25.
70. Martincic M. Toxic effects of Aristolochia clematitis on horses' kidneys [in German]. Vetererinarski Arhiv. 1957;27:51-9.
71. Dumic A. Horse poisoning with Aristolochia clematitis [in Croatian]. In: Zagreb: Izdanje Vojno tehnickog glasnika; 1954. p. 3-45.
72. Chemical Abstracts Registry. Aristolochic acid (electronic number cas 313-67-7). [database on the Internet]. American Chemical Society. 2007. Available from: http:www.cas.org/EO/regsys.html. Accessed: February 7, 2007.
73. Scarborough J. Kidney Disease among the Romans. In: Maver H, Rudan P, editors. Recent advances in endemic nephropathy; 2006; Zagreb, Croatia: Collegium Antropol. 2006;30 Suppl 1:5-6.
74. Ploetz KL. An ethnobotanical study of wild herb use in Bulgaria [M.S. thesis]. Houghton (MI): Michigan Technological University; 2000.